Inhibitors of the Mitochondrial Citrate Transport Protein: Validation of the Role of Substrate Binding Residues and Discovery of the First Purely Competitive Inhibitor
Open Access
- 20 October 2009
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 77 (1), 26-34
- https://doi.org/10.1124/mol.109.058750
Abstract
The mitochondrial citrate transport protein (CTP) is critical to energy metabolism in eukaryotic cells. We demonstrate that 1,2,3-benzenetricarboxylate (BTC), the classic and defining inhibitor of the mitochondrial CTP, is a mixed inhibitor of the reconstituted Cys-less CTP, with a strong competitive component [i.e., a competitive inhibition constant (Kic) of 0.12 ± 0.02 mM and an uncompetitive inhibition constant (Kiu) of 3.04 ± 0.74 mM]. Based on docking calculations, a model for BTC binding has been developed. We then determined the Kic values for each of the eight substrate binding site cysteine substitution mutants and observed increases of 62- to 261-fold relative to the Cys-less control, thereby substantiating the importance of each of these residues in BTC binding. It is noteworthy that we observed parallel increases in the Km for citrate transport with each of these binding site mutants, thereby confirming that with these CTP variants, Km approximates the Kd (for citrate) and is therefore a measure of substrate affinity. To further substantiate the importance of these binding site residues, in silico screening of a database of commercially available compounds has led to discovery of the first purely competitive inhibitor of the CTP. Docking calculations indicate that this inhibitor spans and binds to both substrate sites simultaneously. Finally, we propose a kinetic model for citrate transport in which the citrate molecule sequentially binds to the external and internal binding sites (per CTP monomer) before transport.Keywords
This publication has 25 references indexed in Scilit:
- The yeast mitochondrial ADP/ATP carrier functions as a monomer in mitochondrial membranesProceedings of the National Academy of Sciences of the United States of America, 2007
- Identification of the Substrate Binding Sites within the Yeast Mitochondrial Citrate Transport ProteinJournal of Biological Chemistry, 2007
- The Mitochondrial Citrate Transport ProteinPublished by Elsevier BV ,2004
- Molecular Modeling Study on Dapsone and Sulfonamides Comparing Structures and Properties with Respect to Anti-Leprosy ActivityJournal of Molecular Modeling, 1997
- High-Yield Bacterial Expression, Purification, and Functional Reconstitution of the Tricarboxylate Transport Protein from Rat Liver MitochondriaBiochemical and Biophysical Research Communications, 1995
- High Level Expression and Characterization of the Mitochondrial Citrate Transport Protein from the Yeast Saccharomyces cerevisiaePublished by Elsevier BV ,1995
- Kinetic characterization of the reconstituted tricarboxylate carrier from rat liver mitochondriaBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1990
- The role of the tricarboxylate transporting system in the production of phosphoenolpyruvate by ox liver mitochondriaFEBS Letters, 1971
- The Sensitivity of Exchange Reactions of Tricarboxylate, 2‐Oxoglutarate and Dicarboxylate Transporting Systems of Rat Liver Mitochondria to Inhibition by 2‐Pentylmalonate, p‐Iodobenzylmalonate, and Benzene 1,2,3‐tricarboxylateEuropean Journal of Biochemistry, 1971
- Incorporation of radioactive citrate into fatty acidsBiochimica et Biophysica Acta, 1962